{"id":"https://openalex.org/W2012211347","doi":"https://doi.org/10.1016/s1567-5688(06)81304-8","title":"We-W41:3 Increased levels of IGG1 against an aldehyde-modified peptide sequence in APOB-100 is associated with decreased severity of carotid stenosis","display_name":"We-W41:3 Increased levels of IGG1 against an aldehyde-modified peptide sequence in APOB-100 is associated with decreased severity of carotid stenosis","alternate_titles":[],"publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W2012211347","doi":"https://doi.org/10.1016/s1567-5688(06)81304-8","mag":"2012211347"},"language":"en","primary_location":{"id":"doi:10.1016/s1567-5688(06)81304-8","doi":"https://doi.org/10.1016/s1567-5688(06)81304-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1567-5688(06)81304-8","pdf_url":null,"source":{"id":"https://openalex.org/S120256695","display_name":"Atherosclerosis Supplements","issn_l":"1567-5688","issn":["1567-5688","1878-5050"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","ki-jl-1","poland-20"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Atherosclerosis Supplements","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2012211347"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051390191","display_name":"Gunilla Nordin Fredrikson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G.N. Fredrikson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015844980","display_name":"Andra Maria Schiopu","orcid":"https://orcid.org/0000-0001-9924-7609","observed_orcids":["https://orcid.org/0000-0001-9924-7609"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Schiopu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109099644","display_name":"G Berglund","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Berglund","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040593438","display_name":"Ragnar Alm","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Alm","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007464106","display_name":"Jan\u2010\u00c5ke Nilsson","orcid":"https://orcid.org/0000-0001-8982-1064","observed_orcids":["https://orcid.org/0000-0001-8982-1064"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Nilsson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103009023","display_name":"P.K. Shah","orcid":"https://orcid.org/0000-0002-7178-6106","observed_orcids":["https://orcid.org/0000-0002-7178-6106"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P.K. Shah","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5051390191","display_name":"Gunilla Nordin Fredrikson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G.N. Fredrikson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"7","issue":"3","first_page":"327","last_page":"327"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12955","display_name":"Atherosclerosis and Cardiovascular Diseases","score":0.4690000116825104,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12955","display_name":"Atherosclerosis and Cardiovascular Diseases","score":0.4690000116825104,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10816","display_name":"Cerebrovascular and Carotid Artery Diseases","score":0.2467000037431717,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.13729999959468842,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/apolipoprotein-b-100","display_name":"apolipoprotein B-100","score":0.7900000214576721},{"id":"https://openalex.org/keywords/igg1","display_name":"IgG1","score":0.5569999814033508},{"id":"https://openalex.org/keywords/carotid-stenosis","display_name":"carotid artery stenosis","score":0.8109999895095825},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.6840000152587891},{"id":"https://openalex.org/keywords/autoantibodies","display_name":"autoantibodies","score":0.7099999785423279},{"id":"https://openalex.org/keywords/disease-severity","display_name":"disease severity","score":0.6010000109672546},{"id":"https://openalex.org/keywords/atherosclerotic-plaque","display_name":"atherosclerotic plaque","score":0.640999972820282}],"concepts":[{"id":"https://openalex.org/C2778112365","wikidata":"https://www.wikidata.org/wiki/Q3511065","display_name":"Sequence (biology)","level":2,"score":0.5033060908317566},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5028535723686218},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.47854146361351013},{"id":"https://openalex.org/C62746215","wikidata":"https://www.wikidata.org/wiki/Q14890615","display_name":"Apolipoprotein B","level":3,"score":0.4665519893169403},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3771902322769165},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.26472964882850647},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.23552730679512024},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s1567-5688(06)81304-8","doi":"https://doi.org/10.1016/s1567-5688(06)81304-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1567-5688(06)81304-8","pdf_url":null,"source":{"id":"https://openalex.org/S120256695","display_name":"Atherosclerosis Supplements","issn_l":"1567-5688","issn":["1567-5688","1878-5050"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","ki-jl-1","poland-20"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Atherosclerosis Supplements","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1702700261","https://openalex.org/W2136973506","https://openalex.org/W4251679239","https://openalex.org/W2062430207","https://openalex.org/W1978097281","https://openalex.org/W7095871826","https://openalex.org/W2073230855","https://openalex.org/W4413268469","https://openalex.org/W2029218747","https://openalex.org/W2101016903"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2012211347","counts_by_year":[],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
